PAVM · PAVmed Inc.
$5.04
+0.00 (+0.00%)
At close · Aug 5
Going-concern doubt
— flagged May 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date the accompanying consolidated financial statements are issued.”View the 10-Q filed May 14, 2026
Market Cap
$36.65M
Shares
7.27M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$5.04
Open$5.20
Day$5.04–5.20
52W$3.85–28.44
Avg vol 30d14K
Short int27K · 0.4% float · 2.2d
Short vol48%
Last earningsMay 15, 2026
DataJan 2020–Aug 2026
Filing10-Q · May 14
Up next
Next earnings call
Aug 14, 2026
Est · unconfirmed
· in 1 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 14, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Strong Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Fair
Quant / Vol
Very High
Market backdrop
VIX 15.8 · calm
Equity put/call 0.60
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−41%
below
Price vs 50-day avg
−6%
below
RSI (14)
46
neutral
MACD trend
Negative
52-week position
5%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−6%
trailing
6-month return
−52%
trailing
YTD return
−24%
this year
Relative strength
−63%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $5 › 200d $9 — 200d above 50d
Institutional flow
Flat
3 of 20 funds reported for Jun 30 · net 0 sh shares · +1 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.38% of float · ▼ -18.7% MoM · 2.2 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
20 holders — near 3-yr low, contrarian setup
Squeeze score
31
low risk · 0–100
Fundamentals
Revenue growth
+20%
Y/Y
Gross margin
-3%
EPS growth
−138%
Y/Y
Free cash flow
$-5.2M
Balance sheet
$1.5M
net cash
Quant / Vol
risk profile
Volatility
132%
annualized · 1-yr
Max drawdown
−74%
past year
ATR
9.7%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Strong Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−41%
Bearish
Price vs 50-day avg
−6%
Bearish
RSI (14)
46
Neutral
MACD trend
Negative
Bearish
52-week position
5%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 1 of 6
Trend (MA cross)
No cross
50d $5 › 200d $9 — 200d above 50d
Institutional flow
Flat
3 of 20 funds reported for Jun 30 · net 0 sh shares · +1 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.38% of float · ▼ -18.7% MoM · 2.2 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
20 holders — near 3-yr low, contrarian setup
Price context
position in its 52-week range
52-wk low $4
Now $5 · 5%
52-wk high $28
vs 200-day avg -41%
vs 50-day avg -6%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Non-GAAP adjusted loss non-GAAP | -$1.9M | Q1 2026 | — |
| Proforma cash non-GAAP | 45M | 1Q26 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
PAVM
this stock
PAVmed Inc.
|
$36.65M | -24.0% | +20.0% | — | 0.4% |
|
ABT
Abbott Laboratories
|
$186.86B | -14.1% | +5.7% | 30.1 | 1.4% |
|
SYK
Stryker Corp
|
$129.28B | -3.6% | +11.2% | 34.9 | 1.8% |
|
MDT
Medtronic plc
|
$110.07B | -8.9% | +8.4% | 23.1 | 1.5% |
|
BSX
Boston Scientific Corp
|
$71.45B | -49.9% | +5.5% | 20.0 | 2.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| PAVM | -1.2% | -6.2% | -51.8% | +1.8% | -24.0% |
| SPY | +5.5% | +3.3% | +11.3% | +3.1% | +12.9% |
| vs SPY | -6.7% | -9.5% | -63.1% | -1.2% | -36.9% |